Intermediate for Empagliflozin. Empagliflozin (trade name: Jardiance) is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2). Empagliflozin is used for the treatment of type 2 diabetes in adults. Empagliflozin has been approved by the U.S Food and Drug Administration on August 1, 2014.


Product Name:                  (S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran

Synonyms:                         N/A

CAS Number:                     915095-94-2

Molecular Weight:            414.6697

Molecular Formula:          C17H16ClIO2

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               Ic1ccc(c(c1)Cc1ccc(cc1)O[C@@H]1COCC1)Cl

  • $138.00
  • Ex Tax: $138.00

Available Options